• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源化细胞伪装纳米磁体清除剂可恢复菌血症啮齿动物模型的免疫稳态

Human Cell-Camouflaged Nanomagnetic Scavengers Restore Immune Homeostasis in a Rodent Model with Bacteremia.

机构信息

Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), UNIST gil 50, Ulsan, 44919, Republic of Korea.

出版信息

Small. 2022 Oct;18(40):e2203746. doi: 10.1002/smll.202203746. Epub 2022 Sep 7.

DOI:10.1002/smll.202203746
PMID:36070419
Abstract

Bloodstream infection caused by antimicrobial resistance pathogens is a global concern because it is difficult to treat with conventional therapy. Here, scavenger magnetic nanoparticles enveloped by nanovesicles derived from blood cells (MNVs) are reported, which magnetically eradicate an extreme range of pathogens in an extracorporeal circuit. It is quantitatively revealed that glycophorin A and complement receptor (CR) 1 on red blood cell (RBC)-MNVs predominantly capture human fecal bacteria, carbapenem-resistant (CR) Escherichia  coli, and extended-spectrum beta-lactamases-positive (ESBL-positive) E. coli, vancomycin-intermediate Staphylococcus aureus (VISA), endotoxins, and proinflammatory cytokines in human blood. Additionally, CR3 and CR1 on white blood cell-MNVs mainly contribute to depleting the virus envelope proteins of Zika, SARS-CoV-2, and their variants in human blood. Supplementing opsonins into the blood significantly augments the pathogen removal efficiency due to its combinatorial interactions between pathogens and CR1 and CR3 on MNVs. The extracorporeal blood cleansing enables full recovery of lethally infected rodent animals within 7 days by treating them twice in series. It is also validated that parameters reflecting immune homeostasis, such as blood cell counts, cytokine levels, and transcriptomics changes, are restored in blood of the fatally infected rats after treatment.

摘要

抗微生物药物耐药性病原体引起的血流感染是一个全球性的问题,因为用传统疗法很难治疗。在这里,我们报告了一种由血细胞衍生的纳米囊泡包裹的 scavenger 磁性纳米颗粒(MNVs),它可以在体外循环中通过磁场消除极广泛的病原体。定量研究表明,红细胞(RBC)-MNVs 上的糖蛋白 A 和补体受体(CR)1 主要捕获人类粪便细菌、耐碳青霉烯类(CR)大肠杆菌和产超广谱β-内酰胺酶阳性(ESBL-阳性)大肠杆菌、万古霉素中介金黄色葡萄球菌(VISA)、内毒素和人血中的促炎细胞因子。此外,白细胞-MNVs 上的 CR3 和 CR1 主要有助于耗尽人血中寨卡病毒、SARS-CoV-2 及其变体的病毒包膜蛋白。由于病原体与 MNVs 上的 CR1 和 CR3 之间的组合相互作用,向血液中补充调理素可显著提高病原体清除效率。通过两次连续治疗,体外血液净化可使感染致死的啮齿动物在 7 天内完全恢复。实验还验证了治疗后,致死性感染大鼠血液中的免疫稳态参数(如血细胞计数、细胞因子水平和转录组学变化)得到恢复。

相似文献

1
Human Cell-Camouflaged Nanomagnetic Scavengers Restore Immune Homeostasis in a Rodent Model with Bacteremia.人源化细胞伪装纳米磁体清除剂可恢复菌血症啮齿动物模型的免疫稳态
Small. 2022 Oct;18(40):e2203746. doi: 10.1002/smll.202203746. Epub 2022 Sep 7.
2
Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis.哌拉西林-他唑巴坦与碳青霉烯类药物治疗产超广谱β-内酰胺酶大肠埃希菌菌血症患者的疗效比较:低 OXA-1 共产生率地区的初步分析。
Microbiol Spectr. 2022 Aug 31;10(4):e0220622. doi: 10.1128/spectrum.02206-22. Epub 2022 Aug 2.
3
Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial.美罗培南优化研究(MERINO)中头孢替坦对产 ESBL 大肠埃希菌和肺炎克雷伯菌血流分离株的活性。
Microbiol Spectr. 2021 Sep 3;9(1):e0022621. doi: 10.1128/Spectrum.00226-21. Epub 2021 Jul 7.
4
Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.氟喹诺酮类药物治疗产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌引起的血流感染。
J Microbiol Immunol Infect. 2017 Jun;50(3):355-361. doi: 10.1016/j.jmii.2015.08.012. Epub 2015 Sep 9.
5
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.2001年至2009年重症监护患者中产超广谱β-内酰胺酶的大肠埃希菌和克雷伯菌属的碳青霉烯最低抑菌浓度
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.01718-16. Print 2017 Apr.
6
Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli.产超广谱β-内酰胺酶和不产超广谱β-内酰胺酶的大肠埃希菌所致菌血症重症患者的临床特征及预后
J Infect Chemother. 2018 Nov;24(11):944-947. doi: 10.1016/j.jiac.2018.04.016. Epub 2018 May 24.
7
Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).ESKAPE 和大肠埃希菌引起的血流感染的发生率和抗菌药物耐药趋势:罗马一家大型教学医院的 9 年分析(2007-2015 年)。
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1627-1636. doi: 10.1007/s10096-018-3292-9. Epub 2018 Jun 9.
8
Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.产超广谱β-内酰胺酶大肠埃希菌菌血症的临床转归在一个高流行地区。
Int J Infect Dis. 2013 Feb;17(2):e120-4. doi: 10.1016/j.ijid.2012.09.008. Epub 2012 Oct 23.
9
Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.产超广谱和 AmpC 型β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌菌血症患者的实验室鉴定、危险因素和临床结局。
J Microbiol Immunol Infect. 2012 Jun;45(3):193-9. doi: 10.1016/j.jmii.2011.11.003. Epub 2012 May 12.
10
Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.CTX-M 时代产超广谱β-内酰胺酶大肠埃希菌所致菌血症:一项新的临床挑战。
Clin Infect Dis. 2006 Dec 1;43(11):1407-14. doi: 10.1086/508877. Epub 2006 Oct 25.

引用本文的文献

1
Red Blood Cell-Induced Bacterial Margination Improves Microbial Hemoadsorption on Engineered Cell-Depleted Thrombi, Restoring Severe Bacteremia in Rats.红细胞诱导的细菌边缘化改善了工程化细胞清除血栓上的微生物血液吸附,恢复了大鼠的严重菌血症。
Adv Sci (Weinh). 2025 Aug;12(29):e2417498. doi: 10.1002/advs.202417498. Epub 2025 Apr 26.
2
The impact and safety of encapsulated nanomaterials as a new alternative against carbapenem resistant bacteria. a systematic review.作为一种新的针对耐碳青霉烯类抗生素细菌的替代物,封装纳米材料的影响和安全性:系统评价。
World J Microbiol Biotechnol. 2024 Jan 18;40(2):72. doi: 10.1007/s11274-024-03894-3.